Danish Anapa Biotech in pursuit of global money-spinner

Danish Anapa Biotech has streamlined its business to focus solely on a new molecular diagnostic technology. "We expect to sign one or more agreements with large companies in the foreseeable future," says the CEO.

Photo: Anapa Biotech, PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles